http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#Head
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#assertion
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#provenance
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#pubinfo
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#assertion
http://purl.obolibrary.org/obo/DOID_11330
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_11330
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB01053
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#association
http://www.w3.org/2000/01/rdf-schema#label
to reduce the development of drug resistant bacteria and maintain the effectiveness of penicillin g procaine and other antibacterial drugs penicillin g procaine should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy penicillin g procaine is indicated in the treatment of moderately severe infections in both adults and pediatric patients due to penicillin g susceptible microorganisms that are susceptible to the low and persistent serum levels common to this particular dosage form in the indications listed below therapy should be guided by bacteriological studies including susceptibility tests and by clinical response note when high sustained serum levels are required aqueous penicillin g either im or iv should be used the following infections will usually respond to adequate dosages of intramuscular penicillin g procaine moderately severe to severe infections of the upper respiratory tract skin and soft tissue infections scarlet fever and erysipelas due to susceptible streptococci group a without bacteremia note streptococci in groups a c g h l and m are very sensitive to penicillin g other groups including group d enterococcus are resistant aqueous penicillin is recommended for streptococcal infections with bacteremia moderately severe infections of the respiratory tract due to susceptible pneumococci note severe pneumonia empyema bacteremia pericarditis meningitis peritonitis and arthritis of pneumococcal etiology are better treated with aqueous penicillin g during the acute stage moderately severe infections of the skin and soft tissues due to susceptible staphylococci penicillin g susceptible note reports indicate an increasing number of strains of staphylococci resistant to penicillin g emphasizing the need for culture and sensitivity studies in treating suspected staphylococcal infections indicated surgical procedures should be performed fusospirochetosis vincent s gingivitis and pharyngitis moderately severe infections of the oropharynx due to susceptible fusiform bacilli and spirochetes note necessary dental care should be accomplished in infections involving the gum tissue syphilis all stages due to susceptible treponema pallidum note this drug should not be used in the treatment of beta lactamase producing organisms which include most strains of neisseria gonorrhea yaws bejel pinta due to susceptible organisms penicillin g procaine is an adjunct to antitoxin for prevention of the carrier stage of diphtheria due to susceptible c diphtheriae anthrax due to bacillus anthracis bacillus anthracis rat bite fever due to susceptible streptobacillus moniliformis spirillum minus erysipeloid due to susceptible erysipelothrix rhusiopathia subacute bacterial endocarditis only in extremely sensitive infections due to susceptible group a streptococci
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB01053
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#provenance
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#pubinfo
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#sig
http://purl.org/nanopub/x/hasSignature
WPbIy2J/ESQvrY2fcNvs/uLIbjr2FxzUu/aNJE0ytP6lh2prhDsL4UgcwtYTkCQmqDPbSZR64FDDEskv1ohIRW6Z53XwHysQ9E+Dx6aMrK+pVU3qdkFr+lhNdsyvH59ZkwYP6ME20hbmCDIKsf06KQ9p1X+UKxdRxH32KjhganI=
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I
http://purl.org/dc/terms/created
2021-06-13T16:25:32.420+02:00
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAXRCeCwypoT2smEbChNoJjXbqxOlemMDbxZh53_hLv8I
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs